The effects of EGCG and TG on inflammatory mediator production in raw 264.7 cells challenged with LPS

Biomedical Sciences Instrumentation

Volumn 46, Issue , 2010, Pages

  Wilkins, Renee ^a   Tucci, Michelle ^a   Benghuzzi, Ham ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Antioxidants; Epigallocatechin 3 gallate; Inflammation; Lipopolysaccharide; Macrophages; Thymoquinone

Indexed keywords

CELL NUMBER; CELL VIABILITY; CELLULAR FUNCTION; CELLULAR MORPHOLOGY; CELLULAR PROCESS; EPIGALLOCATECHIN-3-GALLATE; GLUTATHIONES; IMMUNE CELLS; INFLAMMATORY MEDIATORS; INFLAMMATORY PROCESS; LIPOPOLYSACCHARIDES; MALONDIALDEHYDE; PREVENTATIVE EFFECT; PROTECTIVE EFFECTS; REACTIVE OXYGEN SPECIES; SHORT PERIODS; THYMOQUINONE; WATERSOLUBLE;

ALDEHYDES; ANTIGEN-ANTIBODY REACTIONS; MORPHOLOGY; NITRIC OXIDE; OXYGEN; PATHOLOGY;

MACROPHAGES;

BIOLOGICAL MARKER; EPIGALLOCATECHIN GALLATE; GLUTATHIONE; LIPOPOLYSACCHARIDE; MALONALDEHYDE; NITRIC OXIDE; THYMOQUINONE;

ANIMAL CELL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BOLUS INJECTION; CELL COUNT; CELL FUNCTION; CELL LINE; CELL PROTECTION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; MACROPHAGE; MEDIATOR; NONHUMAN;

EID: 77951581117     PISSN: 00678856     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. S. R. Maxwell, "Prospects for the use of antioxidant therapies," Drugs, 49(3), 345-361, 1995.
2. M. A. El-Gazzar, R. El Mezayen, J. C. Marechi, M. R. Nicolls, A. Canastar, and S. C. Dreskin, "Thymoquinone attenuates proinflammatory responses in lipopolysaccharide-activated mast cells by modulating NF-kappaB nuclear transactivation," Biochimica et Biophysica Acta, 1770(4), 556-564, 2007.
3. M. Roepke, A. Diestel, K. Bajbouj, d. Walluscheck, P. Schonfeld, A. Roessner, et al, "Lack of p53 augments thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells," Cancer Biology & Therapy, 6(2), 160-169, 2007.
4. A. Osterburg, J. Gardner, S. H. Hyon, A. Neely, B. Babcock, "Highly antibiotic-resistant Acinetobacter aumannii clinical isolates are killed by the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG)," Clinical Microbiology and Infection, 15(4), 341-346, 2009.
5. G. Peng, D. A. Dixon, S. J. Muga, T. J. Smith, and M. J. Wargovich, "Green tea polyphenols (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis," Molecular Carcinogenesis, 45(5), 309-319, 2006. (Pubitemid 43749198)
6. H. S. Youn, J. Y. Lee, S. I. Saitoh, K. Miyake, K. W. Kang, Y. J. Choi, et al, "Suppression of MyD88-TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea," Biochemical Pharmacology, 72(7), 850-859, 2006. (Pubitemid 44313886)
7. M. L. Salem, "Immunomodulatory and therapeutic properties of the Nigella sative L. seed," International Immunopharmacology, 5(13-14), 1749-1770, 2005.
8. A. A. Norwood, M. Tan, M. May, M. Tucci, and H. Benghuzzi, "Comparison of potential chemotherapeutic agents, 5-fluoruracil, green tea, and thymoquinone on colon cancer cells," Biomedical Sciences Instrumentation, 42, 350-356, 2006. (Pubitemid 43911280)
9. M. Tan, A. Norwood, M. May, M. Tucci, and H. Benghuzzi, "Effects of(-)-epigallocatechin gallate and thymoquinone on proliferation of PANC-1 cell line in culture," Biomedical Sciences Instrumentation, 42, 363-371
10. M. A. Baker, G. J. Cerniglia, A. Zaman, "Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples," Analytical Biochemistry, vol.190, pp. 360-365, 1990.
11. V. Sampath, A. C. Radish, A. L. Eis, K. Broniowska, N. Hogg and G. G. Konduri, "Attenuation of lipopolysaccharide-induced oxidative stress and apoptosis in fetal pulmonary artery endothelials cells by hypoxia," Free Radical Biology & Medicine, 46, 663-671, 2009.
12. S. Y. Lyu and W. B. Park, "Production of cytokine and NO by RAW 264.7 macrophages and PBMC in vitro incubation with flavonoids," Archives of Pharmacal Research, 28(5), 573-581, 2005.
13. A. El-mahmoudy, Y. Shimizu, T. Shiina, H. Matsuyama, H. Nikami and T. Takewaki, "Macrophage-derived cytokine and nitric oxide profiles in type I and type II diabetes mellitus: effect of thymoquinone," Acta Diabetologica, 42(1), 23-30, 2005.
14. J. K. Lin, Y. C. Liang, S. Y. Lin-Shiau, "Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade," Biochemical Pharmacology, 58(6), 911-915, 1999.